San Francisco, CA7 Active Studies

Lupus Nephritis Clinical Trials in San Francisco, CA

Find 7 actively recruiting lupus nephritis clinical trials in San Francisco, CA. Connect with local research sites and explore new treatment options.

7
Active Trials
7
Sponsors
1,494
Enrolling

Recruiting Lupus Nephritis Studies in San Francisco

About Lupus Nephritis Clinical Trials in San Francisco

Lupus nephritis is kidney inflammation caused by systemic lupus erythematosus, occurring in up to 60% of SLE patients. It can lead to kidney failure if untreated. Treatment includes immunosuppressive medications such as mycophenolate, cyclophosphamide, and newer agents like voclosporin.

There are currently 7 lupus nephritis clinical trials recruiting participants in San Francisco, CA. These studies are seeking a combined 1,494 participants. Research is being sponsored by Massachusetts General Hospital, Children's Hospital Medical Center, Cincinnati, Regeneron Pharmaceuticals and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lupus Nephritis Clinical Trials in San Francisco — FAQ

Are there lupus nephritis clinical trials in San Francisco?

Yes, there are 7 lupus nephritis clinical trials currently recruiting in San Francisco, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in San Francisco?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the San Francisco research site will contact you about next steps.

Are clinical trials in San Francisco free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many San Francisco studies also compensate for your time and travel.

What lupus nephritis treatments are being tested?

The 7 active trials in San Francisco are testing new therapies including novel drugs, biologics, and treatment approaches for lupus nephritis.

Data updated October 17, 2026 from ClinicalTrials.gov